Retina is a Marker for Cerebrovascular Heath

Whomever wrote this didn't know that stroke has been called neurological disease by the WHO since 2006 not cerebrovascular, once again proving the stroke medical world doesn't keep up to date in their field!

Retina is a Marker for Cerebrovascular Heath

ClinicalTrials.gov ID NCT04753970

Sponsor:Mayo Clinic 

Information Provided by:Michelle P Lin, MD, MPH 

Study Start (Actual)2021-02-09 

Primary Completion (Estimated) 2026-06 

Study Completion (Estimated)2026-06 

Enrollment (Estimated)100 

Study Type: Interventional 

Last Update Posted2025-07-23 Study Overview

Brief Summary

Cerebral small vessel disease (SVD), present in 80-94% of adults over age 65 years, increases the risk of stroke by 2-fold, and dementia by 2.3-fold. There is currently no treatment to slow SVD progression. This study aims to test whether impaired cerebral and retinal vasoreactivity may serve as biomarker for SVD progression, and to evaluate the safety and efficacy of cilostazol (antiplatelet agent with vasodilatory and anti-inflammatory properties) for the treatment of SVD.

ClinicalTrials.gov